Value Pathways and Quality Initiatives
Payers are increasingly linking quality patient care and cost-savings in a move toward value-based reimbursement. McKesson offers solutions that can help you develop a quality program to meet the changing landscape.
Value Pathways powered by NCCN™ are treatment pathways that highlight evidence-based treatment options based on efficacy, toxicity and an evaluation of financial impact to patient and payor (Medicare reimbursement). The pathways are a refinement of the NCCN Guidelines and the result of combined efforts through a collaboration between three organizations: NCCN, McKesson and The US Oncology Network. Value Pathways powered by NCCN is a shorter, distilled list of treatment choices that support the delivery of high-quality, cost-effective patient care.
- Value Pathways powered by NCCN mission and committee description
- Pathways Task Force disclosure summary
Clear Value PlusSM is a simple and powerful tool for physicians that highlights evidence-based treatment options and provides clinical and financial information at the point of care. The software presents Value Pathways powered by NCCN and NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®) within the clinical workflow — for the first time offering integrated financial information, real-time reporting and benchmarking, and the ability to integrate with the provider’s electronic health record (EHR).
Value Pathways powered by NCCN Pharmacoeconomic Submission Process
The Pathways Task Force will consider data that may be useful in evaluating the pharmacoeconomic impact of a treatment option for inclusion in a Value Pathway. For more information, view: